FactorPad
Build a Better Process

Stock Risk Measures for Sage Therapeutics Inc

A quantitative factor review as of August 31, 2021.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
face pic by Paul Alan Davis, CFA
Updated: September 04, 2021
See how we arrive at an overall risk score of 51 for SAGE below.

/ factorpad.com / stocks / f93pnb.html


An ad-free and cookie-free website.


SAGE Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Sage Therapeutics Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how SAGE stock compares to 2,000+ US-based stocks, and to peers in the Manufacturing sector and Pharmaceutical Preparation Manufacturing industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. The Company is pursuing new pathways with the goal of improving brain health, and its depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Its mission is to make medicines that matter so people can get better, sooner.

Identity

Sector and Industry

Share Data

Shares

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f93pnb.html


SAGE stock risk
SAGE THERAPEUTICS INC stock beta
SAGE risk report
SAGE f93pnb
SAGE risk analysis
SAGE volatility
SAGE THERAPEUTICS INC credit risk
SAGE liquidity risk
SAGE leverage
SAGE valuation
SAGE systematic risk
SAGE specific risk
SAGE THERAPEUTICS INC volatility
SAGE analysis
SAGE financial ratio

A newly-updated free resource. Connect and refer a friend today.